Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 13, 2014 16:06 ET | Source: Daré Bioscience, Inc.

Cerulean Reports Third-Quarter 2014 Corporate Highlights and Financial Results

CAMBRIDGE, Mass., Nov. 13, 2014 (GLOBE NEWSWIRE) -- Cerulean Pharma Inc. (Nasdaq:CERU), a leader in Dynamic Tumor Targeting™, today provided an update on corporate activities during the quarter...
October 30, 2014 08:01 ET | Source: Daré Bioscience, Inc.

Cerulean to Host Third-Quarter 2014 Conference Call on November 13

CAMBRIDGE, Mass., Oct. 30, 2014 (GLOBE NEWSWIRE) -- Cerulean Pharma Inc. (Nasdaq:CERU), a leader in Dynamic Tumor Targeting™, today announced it will provide an update on corporate activities...
October 27, 2014 16:02 ET | Source: Daré Bioscience, Inc.

Cerulean Pharma Appoints David Parkinson, M.D., to Board of Directors

CAMBRIDGE, Mass., Oct. 27, 2014 (GLOBE NEWSWIRE) -- Cerulean Pharma Inc. (Nasdaq:CERU), a leader in Dynamic Tumor Targeting™, today announced the appointment of clinical oncology expert, David...
October 27, 2014 16:01 ET | Source: Daré Bioscience, Inc.

Cerulean Announces Management Changes

CAMBRIDGE, Mass., Oct. 27, 2014 (GLOBE NEWSWIRE) -- Cerulean Pharma Inc. (Nasdaq:CERU), a leader in Dynamic Tumor Targeting™, today announced that Oliver Fetzer, Ph.D., has resigned as President...
October 08, 2014 08:59 ET | Source: Daré Bioscience, Inc.

Cerulean Appoints Susan L. Kelley, M.D., to Its Board of Directors

CAMBRIDGE, Mass., Oct. 8, 2014 (GLOBE NEWSWIRE) -- Cerulean Pharma Inc. (Nasdaq:CERU), a leader in Dynamic Tumor Targeting™, today announced the addition of Susan L. Kelley, M.D., to the...
October 06, 2014 09:02 ET | Source: Daré Bioscience, Inc.

Cerulean Appoints Vice President, Regulatory Affairs

CAMBRIDGE, Mass., Oct. 6, 2014 (GLOBE NEWSWIRE) -- Cerulean Pharma Inc. (Nasdaq:CERU), a leader in Dynamic Tumor Targeting™, today announced the appointment of Pamela Strode as Vice President,...
September 29, 2014 09:01 ET | Source: Daré Bioscience, Inc.

Cerulean Appoints General Counsel

CAMBRIDGE, Mass., Sept. 29, 2014 (GLOBE NEWSWIRE) -- Cerulean Pharma Inc. (Nasdaq:CERU), a leader in Dynamic Tumor Targeting™, today announced the appointment of Alejandra Carvajal as Vice...
September 18, 2014 09:01 ET | Source: Daré Bioscience, Inc.

Cerulean to Present at BioCentury's Newsmakers in Biotechnology Conference

CAMBRIDGE, Mass., Sept. 18, 2014 (GLOBE NEWSWIRE) -- Cerulean Pharma Inc. (Nasdaq:CERU), a leader in Dynamic Tumor Targeting™, today announced that Oliver S. Fetzer, Ph.D., President and Chief...
August 12, 2014 16:07 ET | Source: Daré Bioscience, Inc.

Cerulean Reports Second Quarter 2014 Corporate Highlights and Financial Results

CAMBRIDGE, Mass., Aug. 12, 2014 (GLOBE NEWSWIRE) -- Cerulean Pharma Inc. (Nasdaq:CERU), a leader in Dynamic Tumor Targeting™, today provided an update on corporate activities during the quarter...
August 06, 2014 09:00 ET | Source: Daré Bioscience, Inc.

Cerulean to Present at Upcoming Conferences

CAMBRIDGE, Mass., Aug. 6, 2014 (GLOBE NEWSWIRE) -- Cerulean Pharma, Inc. (Nasdaq:CERU), a leader in Dynamic Tumor Targeting™, today announced that Oliver S. Fetzer, Ph.D., President and Chief...